Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Adam, Pawinski"'
Publikováno v:
International Journal of Circumpolar Health, Vol 76, Iss 1 (2017)
The aim of this study was to reduce barriers that prevent implementation of evidence-based recommendations about single-fraction palliative radiotherapy (PRT) and to demonstrate that single-fraction PRT yields similar outcomes as long-course treatmen
Externí odkaz:
https://doaj.org/article/e73bd7ca41384987a69567e1979a4cec
Publikováno v:
The Scientific World Journal, Vol 11, Pp 1178-1186 (2011)
In this paper, we analyze predictive factors for early death from comorbidity (defined as death within 3 years from diagnosis and unrelated to prostate cancer) in patients with localized or locally advanced prostate cancer. Such information may guide
Externí odkaz:
https://doaj.org/article/d4c8e71a67f3410da09d6b74b7063119
Publikováno v:
Journal of Clinical Medicine Research
Background: The aim of this study was to validate the prognostic impact of the recently introduced three-tiered LabBM score in patients with brain metastases. In contrast to the previous development and validation cohorts, the present cohort did not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c48742eff8b17b55f7fd5f8276fe2f7
https://doi.org/10.14740/jocmr3746
https://doi.org/10.14740/jocmr3746
Autor:
Carsten Nieder, Adam Pawinski
Publikováno v:
Case Reports in Oncological Medicine, Vol 2014 (2014)
Elderly patients with breast cancer often present with symptomatic, locoregionally advanced rather than screening-detected disease, thereby increasing the risk of metastatic recurrence during their remaining life time. Typical sites of metastases inc
Externí odkaz:
https://doaj.org/article/e7204b6bc31f40ed81e64d86df6fc2ea
Background/aim Previous research has suggested that patients with metastatic renal cell cancer (mRCC) and bone metastases have a poorer prognosis compared to their counterparts with no skeletal involvement. Therefore, we analyzed the management and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774d57452ec8ad273e8a3eeda2d60ae9
https://europepmc.org/articles/PMC7157836/
https://europepmc.org/articles/PMC7157836/
Background/Aim: The aim of this study was to analyze the survival of patients with brain metastases treated with best supportive care or additional whole-brain radiotherapy (WBRT), in order to confirm results from the prospective randomized QUARTZ st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ea37ea3e1476d19c3a1904148f559c
https://hdl.handle.net/10037/20731
https://hdl.handle.net/10037/20731
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34300 (2012)
Research activity related to different aspects of prevention, prediction, diagnosis and treatment of brain metastases has increased during recent years. One of the major databases (Scopus) contains 942 scientific articles that were published during t
Externí odkaz:
https://doaj.org/article/4b1fb61b78b540bc8a6538eafdc98ae8
Publikováno v:
Anticancer Research. 39:335-340
Background/Aim: Compared to intravenous taxane chemotherapy, newer orally-available and/or less toxic agents for metastatic castration-resistant prostate cancer (MCRPC) may be associated with higher likelihood of starting treatment in patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d4e545965859efd090aeeb6fcfd91f7
https://doi.org/10.21873/anticanres.13116
https://doi.org/10.21873/anticanres.13116
Publikováno v:
Strahlentherapie und Onkologie. 194:533-538
Widely used prognostic scores, e. g., for brain or bone metastases, are based on disease- and patient-related factors such as extent of metastases, age and performance status, which were available in the databases used to develop the scores. Few grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d42289e1e045cddd526fb4981b524c3
https://doi.org/10.1007/s00066-018-1259-5
https://doi.org/10.1007/s00066-018-1259-5
Autor:
Rosalba Yobuta, Terje Tollåli, Anne Reigstad, Liv Randi Flatøy, Carsten Nieder, Adam Pawinski
Publikováno v:
Journal of Clinical Medicine Research
Background: Effective symptom palliation can be achieved with low-dose palliative thoracic radiotherapy. In several studies, median survival was not improved with higher doses of radiation. More controversy exists regarding the impact of higher doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::768cf54e272034ba2ab32d84ed7bd0f1
http://europepmc.org/articles/PMC5412521
http://europepmc.org/articles/PMC5412521